Listopad 2021.: Kabozantinib (Cabometyx, Exelixis, Inc.) odobrila je Uprava za hranu i lijekove za odrasle i pedijatrijske pacijente u dobi od 12 i više godina koji imaju lokalno uznapredovale ili metastatske diferencirane štitnjače.
Lenvatinib (Lenvima) New oral anticancer drug Lenvima (lenvatinib) has recently been approved by Japan for the treatment of unresectable thyroid cancer. This is another important market that the drug has captured since it was app..